Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Kabiven is used in parenteral nutrition to support protein and nitrogen requirements in patients with limited oral or enteral intake.

• Inadequate oral or enteral intake: supplies essential amino acids to maintain nitrogen balance and support protein synthesis.
• Post‑operative surgical patients: provides amino acids needed for wound healing and recovery of lean body mass.
• Critically ill intensive‑care patients: helps meet heightened metabolic demands and prevents catabolism during severe illness.

• Kabiven delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, replenish intracellular pools, and contribute to nitrogen balance. By providing these building blocks, the solution supports tissue repair, immune function and metabolic processes in patients who cannot obtain nutrition through the gastrointestinal tract. The formulation is isotonic and designed to be compatible with other parenteral nutrition components.

Kabiven may be associated with infusion‑related and metabolic adverse reactions.

Common Side Effects

• Hyperglycemia: elevated blood glucose levels during infusion.
• Electrolyte imbalance: changes in serum potassium, sodium or calcium.
• Phlebitis: inflammation at the intravenous site.
• Mild fever: transient increase in body temperature.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate treatment.
• Metabolic acidosis: significant drop in blood pH.
• Renal impairment: worsening kidney function in susceptible patients.
• Sepsis related to catheter: bloodstream infection associated with the infusion line.

When using Kabiven, clinicians should observe several safety considerations to minimize risks.

• Assess renal function: adjust infusion volume in patients with impaired kidney function.
• Monitor blood glucose: amino acid load can affect glucose homeostasis.
• Check electrolyte status: supplementation may be required to maintain balance.
• Use aseptic technique: prevent microbial contamination of the infusion.
• Observe for signs of hypersensitivity: discontinue if allergic reaction occurs.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with certain intravenous therapies and medications, requiring attention to compatibility and patient monitoring.

Major Interactions (Avoid)

• Concurrent high‑dose potassium: risk of hyperkalemia.
• Incompatible IV solutions: precipitation may occur with calcium‑containing admixtures.
• Renal replacement therapy: significant removal of amino acids reducing efficacy.

Moderate Interactions (Monitor Closely)

• Insulin therapy: may need dose adjustment due to glucose changes.
• Diuretics: monitor electrolytes closely.
• Other parenteral nutrition components: balance osmolarity and nutrient ratios.